2025-01-18 06:42:39
Ascletis Announces Approval of Phase II Clinical Trial of ASC22 (Envafolimab) by China NMPA for Immune Restoration/Functional Cure of HIV-1 Infected Patients
Corporate/ 2023-07-23
Ascletis Announces Approval of Phase II ...

HANGZHOU,Chinaand SHAOXING,China,Nov. 10,2021--Ascletis Pharma Inc. (HKEX: 1672) today announces the approval of the Phase II clinical trial...

AffaMed Therapeutics Announces the Establishment of AffaMed Digital to Advance Digital Medicines
Health/ 2023-07-22
AffaMed Therapeutics Announces the Estab...

SHANGHAI,Nov. 10,2021--AffaMed Therapeutics ("AffaMed"),a global clinical-stage therapeutic company dedicated to developing and co...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release